Shanghai, China

Xiao-Ming Yang


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):

Title: Innovations of Xiao-Ming Yang in Medicinal Chemistry

Introduction

Xiao-Ming Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address renal and cardiac dysfunction. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Xiao-Ming Yang holds a patent for a compound known as Medicarpin and its derivatives. The patent outlines a manufacturing method for this compound, which is designed to treat renal and cardiac dysfunction. The compound's formula is defined in the specification, detailing each variable in the formula. The invention also includes a method for administering an effective amount of the compound, along with a pharmaceutical acceptable salt and carrier, to subjects in need of treatment.

Career Highlights

Xiao-Ming Yang is associated with Phytohealth Corporation, where he continues to advance his research and development efforts. His work at the company reflects a commitment to harnessing the potential of natural compounds for therapeutic applications.

Collaborations

Xiao-Ming Yang collaborates with notable colleagues in his field, including Kuo-Hsiung Lee and Rong-Tsun Wu. These partnerships enhance the scope of his research and contribute to the innovative solutions being developed at Phytohealth Corporation.

Conclusion

Xiao-Ming Yang's contributions to medicinal chemistry, particularly through his patent on Medicarpin, highlight his role as an influential inventor. His work not only showcases his innovative spirit but also aims to provide effective treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…